Pfizer Income Statement
View: Annual | Quarterly
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|
|---|---|---|---|---|---|
| Revenue | 11,848.0 | 12,870.0 | 11,990.0 | 11,084.0 | 12,474.0 |
| Cost of Goods Sold | 1,986.0 | 2,625.0 | 4,618.0 | 2,109.0 | 1,887.0 |
| Gross Profit | 9,862.0 | 10,245.0 | 7,372.0 | 8,975.0 | 10,587.0 |
| Gross Profit Margin | 83.2% | 79.6% | 61.5% | 81.0% | 84.9% |
| SG&A Expense | 5,151.0 | 6,769.0 | 5,624.0 | 6,804.0 | 5,263.0 |
| Depreciation & Amortization | 1,487.0 | 1,116.0 | 1,372.0 | 1,441.0 | 1,271.0 |
| Operating Income | 3,224.0 | 2,360.0 | 376.0 | 730.0 | 4,053.0 |
| Operating Margin | 27.2% | 18.3% | 3.1% | 6.6% | 32.5% |
| Nonoperating Income | 333.0 | 1,007.0 | 260.0 | 889.0 | -- |
| Nonoperating Expenses | -- | 397.0 | -- | -- | -- |
| Income Before Taxes | 3,557.0 | 2,970.0 | 636.0 | 1,619.0 | 4,053.0 |
| Income Taxes | 763.0 | 223.0 | (161.0) | 272.0 | 689.0 |
| Net Income After Taxes | 2,794.0 | 2,747.0 | 797.0 | 1,347.0 | 3,364.0 |
| Continuing Operations | 2,788.0 | 2,711.0 | 796.0 | 1,345.0 | 3,361.0 |
| Discontinued Operations | (4.0) | 13.0 | (35.0) | (78.0) | 31.0 |
| Total Operations | 2,784.0 | 2,724.0 | 761.0 | 1,267.0 | 3,392.0 |
| Total Net Income | 2,784.0 | 2,724.0 | 761.0 | 1,267.0 | 3,392.0 |
| Net Profit Margin | 23.5% | 21.2% | 6.3% | 11.4% | 27.2% |
| Diluted EPS from Total Net Income ($) | 0.41 | 0.39 | 0.12 | 0.18 | 0.48 |
| Dividends per Share | 0.32 | 0.29 | 0.29 | 0.29 | 0.29 |






